Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 7—July 2007


Antimicrobial Drugs and Community-acquired Methicillin-Resistant Staphylococcus aureus, United Kingdom

Verena Schneider-Lindner*†, J. A. Delaney*†, Sandra Dial†‡, Andre Dascal‡, and Samy Suissa*†Comments to Author 
Author affiliations: *McGill University Health Center, Montreal, Quebec, Canada; †Royal Victoria Hospital, Montreal, Quebec, Canada; ‡Sir Mortimer B. Davis–Jewish General Hospital, Montreal, Quebec, Canada;

Main Article

Table 1

Characteristics of patients with (case-patients) and without (control-patients) a diagnosis of community-acquired methicillin-resistant Staphylococcus aureus*

Lifestyle factors
Smoking 718 (36.2) 6,365 32.2) 1.21 1.06 0.95–1.17
Obesity 323 (16.3) 2,253 (11.4) 1.54 1.27 1.10–1.47‡

*Data from the General Practice Research Database, United Kingdom, 2000–2004. OR, odds ratio; CI, confidence interval; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease.
†Adjusted for all other variables in the table and exposure to antimicrobial drugs in the 30–365 days period before the index date.

Main Article